APREA THERAPEUTICS INC's ticker is and the CUSIP is 03836J902. A total of 1 filers reported holding APREA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,610 | -51.4% | 98,200 | -1.4% | 0.00% | – |
| Q3 2022 | $65,000 | -27.8% | 99,600 | -18.4% | 0.00% | – |
| Q2 2022 | $90,000 | -43.4% | 122,000 | +42.5% | 0.00% | – |
| Q1 2022 | $159,000 | +1035.7% | 85,600 | +1646.9% | 0.00% | – |
| Q4 2021 | $14,000 | -84.4% | 4,900 | -72.2% | 0.00% | – |
| Q3 2021 | $90,000 | -54.5% | 17,600 | -56.7% | 0.00% | – |
| Q2 2021 | $198,000 | +19700.0% | 40,600 | +20200.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |